We are monitoring the impact of COVID-19 on Europe Superdisintegrants Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2747
Share on
Share on

Europe Superdisintegrants Market Research Report – Segmented By Product Type, Application, Therapeutic Area & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Trends, Forecast, Growth | 2019 - 2024

Pulished: February, 2020
ID: 2747
Pages: 140

Europe Superdisintegrants Market Size & Growth (2019 – 2024):

According to the Report, the Size of the Europe Superdisintegrants Market is valued at USD 83.09 million in 2019 and estimated to be growing at a CAGR of 7.2%, to reach USD 117.63 million by 2024 during the forecast period 2019-2024

Excipients are the substance that is fabricated alongside medicating ingredients for the purpose of long-term stabilization, bulking up solid contents, etc. Superdisintegrants are one of the types of excipients that help in fragmenting and dissolving the tablet when contacted with water. It provides advantages like faster-medicating action increased effectiveness. Increasing healthcare expenditure and healthcare awareness among individuals has accounted for the growth of this market.

The factors accountable for the growth of the market are growing generic drugs market, the growing population of geriatric and pediatric patients and the development of new superdisintegrants in the pharmaceutical industry. However, the growth of the market is slowed by the declining financial support for R&D fields. Although synthetic superdisintegrants have been the standard for many decades now, greater research into natural super disintegrants will provide a motivation for the future growth of the market.

Europe Superdisintegrants Market has been segmented and sub-segmented into the following categories

  • By Product Type: Natural Superdisintegrants, Synthetic Superdisintegrants.
  • By Application: Capsules, Tablets.
  • By Therapeutic Area: Gastrointestinal diseases, Neurological diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Hematological diseases, Inflammatory Diseases.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

On the basis of product type, the synthetic super disintegrant market segment held the largest share of the North America superdisintegrants market.

On the basis of therapeutic area, rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand of fast disintegrating tablets, in-turn driving the demand of super disintegrants during the forecast period.

On the basis of region, the U.K. is leading the market while Germany is in second place. Increasing financial support for the development of innovative oral dosage forms and constant effort devoted towards providing superior quality and compliant products in the market are the primary factors responsible for the dominance of the U.K and Germany in the market. Germany is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure, and awareness.

Prominent Companies leading the Europe Superdisintegrants Market Profiled in the Report are Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co., and Huber Corporation.

1.Introduction               

                1.1 Market Definition 

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods       

                1.4 General Study Assumptions 

2. Research Methodology                        

                2.1 Introduction            

                2.2 Research Phases   

                                2.2.1 Secondary Research

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design      

                2.4 Study Timeline       

3. Overview                    

                3.1 Executive Summary 

                3.2 Key Inferences      

                3.3 Epidemology           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                             

                4.1 Market Drivers       

                4.2 Market Restraints 

                4.3 Key Challenges      

                4.4 Current Opportunities in the Market           

5. Market Segmentation                           

                5.1 Product Type          

                                5.1.1 Introduction 

                                5.1.2 Natural Superdisintegrants    

                                5.1.3 Synthetic Superdisintegrants

         5.1.3.1 Modified Starch                                

         5.1.3.2 Crospovidone                                    

         5.1.3.3 Modified Cellulose    

         5.1.3.4 Ion Exchange Resins 

         5.1.3.5 Calcium Silicates                                

                                5.1.4 Others      

                                5.1.5  Y-o-Y Growth Analysis, By Product Type   

                                5.1.6  Market Attractiveness Analysis, By Product Type

                                5.1.7  Market Share Analysis, By Product Type   

                5.2 Application

                                5.2.1 Introduction 

                                5.2.2 Capsules  

                                5.2.3 Tablets      

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application       

                                5.2.6 Market Share Analysis, By Application        

                5.3 Therapeutic Area  

                                5.3.1 Introduction 

                                5.3.2 Gastrointestinal diseases  

                                5.3.3 Neurological diseases         

                                5.3.4 Oncology 

                                5.3.5 Infectious Diseases   

                                5.3.6 Cardiovascular Diseases    

                                5.3.7 Haematological diseases   

                                5.3.8 Inflammatory Diseases      

                                5.3.9 Y-o-Y Growth Analysis, By Therapeutic Area  

                                5.3.10  Market Attractiveness Analysis, By Therapeutic Area       

                                5.3.11  Market Share Analysis, By Therapeutic Area         

6. Geographical Analysis                           

                6.1 Introduction            

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

         6.1.3.1 By Geographical Area                                     

         6.1.3.2 By Product Type                                

         6.1.3.3 By Application                                    

         6.1.3.4 By Therapeutic Area 

                                6.1.4  Market Attractiveness Analysis     

         6.1.4.1 By Geographical Area                                     

         6.1.4.2 By Product Type                                

         6.1.4.3 By Application                                    

         6.1.4.4 By Therapeutic Area 

                                6.1.5  Market Share Analysis      

         6.1.5.1 By Geographical Area                                     

         6.1.5.2 By Product Type                                

         6.1.5.3 By Application                                    

         6.1.5.4 By Therapeutic Area 

                6.2 U.K

                6.3 Spain          

                6.4 Germany  

                6.5 Italy            

                6.6 France       

7.Strategic Analysis                     

                7.1 PESTLE analysis      

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis           

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services    

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                      

                8.1 Ashland     

                                8.1.1 Overview 

                                8.1.2 Product Type Analysis        

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View

                8.2 BASF SE     

                8.3 FMC Corporation  

                8.4 JRS Pharma

                8.5 DFE Pharma 

                8.6 Roquette  

                8.7 The Dow Chemical Company           

                8.8 Asahi Kasei Corporation     

                8.9 Nippon Soda Co.   

                8.10 Huber Corporation 

9.Competitive Landscape                         

                9.1 Market share analysis         

                9.2 Merger and Acquisition Analysis    

                9.3 Agreements, collaborations and Joint Ventures      

                9.4 New Product Launches      

10.Market Outlook and Investment Opportunities                       

Appendix                        

                a) List of Tables                                     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Superdisintegrants Market By Product Type, From 2019-2024 ( USD Million )
  2. Europe Natural Superdisintegrants Market By Region, From 2019-2024 ( USD Million )
  3. Europe Synthetic Superdisintegrants Market By Region, From 2019-2024 ( USD Million )
  4. Europe Superdisintegrants Market By Application, From 2019-2024 ( USD Million )
  5. Europe Capsules Market By Region, From 2019-2024 ( USD Million )
  6. Europe Tablets Market By Region, From 2019-2024 ( USD Million )
  7. Europe Superdisintegrants Market By Therapeutic Area, From 2019-2024 ( USD Million )
  8. Europe Gastrointestinal Diseases Market By Region, From 2019-2024 ( USD Million )
  9. Europe Neurological Diseases Market By Region, From 2019-2024 ( USD Million )
  10. Europe Oncology Market By Region, From 2019-2024 ( USD Million )
  11. Europe Infectious Diseases Market By Region, From 2019-2024 ( USD Million )
  12. Europe Cardiovascular Diseases Market By Region, From 2019-2024 ( USD Million )
  13. Europe Haematological Diseases Market By Region, From 2019-2024 ( USD Million )
  14. Europe Inflammatory Diseases Market By Region, From 2019-2024 ( USD Million )
  15. U.K. Superdisintegrants Market By Product Type, From 2019-2024 ( USD Million )
  16. U.K. Superdisintegrants Market By Application, From 2019-2024 ( USD Million )
  17. U.K. Superdisintegrants Market By Therapeutic Area, From 2019-2024 ( USD Million )
  18. Germany Superdisintegrants Market By Product Type, From 2019-2024 ( USD Million )
  19. Germany Superdisintegrants Market By Application, From 2019-2024 ( USD Million )
  20. Germany Superdisintegrants Market By Therapeutic Area, From 2019-2024 ( USD Million )
  21. France Superdisintegrants Market By Product Type, From 2019-2024 ( USD Million )
  22. France Superdisintegrants Market By Application, From 2019-2024 ( USD Million )
  23. France Superdisintegrants Market By Therapeutic Area, From 2019-2024 ( USD Million )
  24. Italy Superdisintegrants Market By Product Type, From 2019-2024 ( USD Million )
  25. Italy Superdisintegrants Market By Application, From 2019-2024 ( USD Million )
  26. Italy Superdisintegrants Market By Therapeutic Area, From 2019-2024 ( USD Million )
  27. Spain Superdisintegrants Market By Product Type, From 2019-2024 ( USD Million )
  28. Spain Superdisintegrants Market By Application, From 2019-2024 ( USD Million )
  29. Spain Superdisintegrants Market By Therapeutic Area, From 2019-2024 ( USD Million )
  30. Europe Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  31. Europe Modified Starch Market By Region, From 2019-2024 ( USD Million )
  32. Europe Crospovidone Market By Region, From 2019-2024 ( USD Million )
  33. Europe Modified Cellulose Market By Region, From 2019-2024 ( USD Million )
  34. Europe Ion Exchange Resins Market By Region, From 2019-2024 ( USD Million )
  35. Europe Calcium Silicates Market By Region, From 2019-2024 ( USD Million )
  36. U.K. Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  37. Germany Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  38. France Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  39. Italy Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  40. Spain Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  41. Europe Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  42. Europe Modified Starch Market By Region, From 2019-2024 ( USD Million )
  43. Europe Crospovidone Market By Region, From 2019-2024 ( USD Million )
  44. Europe Modified Cellulose Market By Region, From 2019-2024 ( USD Million )
  45. Europe Ion Exchange Resins Market By Region, From 2019-2024 ( USD Million )
  46. Europe Calcium Silicates Market By Region, From 2019-2024 ( USD Million )
  47. U.K. Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  48. Germany Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  49. France Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  50. Italy Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )
  51. Spain Superdisintegrants Market By Synthetic Superdisintegrants, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample